Severe acute respiratory syndrome coronavirus-2 and the deduction effect of angiotensin-converting enzyme 2 in pregnancy.


Journal

Journal of the Chinese Medical Association : JCMA
ISSN: 1728-7731
Titre abrégé: J Chin Med Assoc
Pays: Netherlands
ID NLM: 101174817

Informations de publication

Date de publication:
09 2020
Historique:
entrez: 9 9 2020
pubmed: 10 9 2020
medline: 22 9 2020
Statut: ppublish

Résumé

The 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) is a pandemic disease worldwide. The spread of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is continuing at a rapid speed. Till May 4, 2020, there have been 3,407,747 confirmed cases and 238,198 deaths globally. The common symptoms in pregnant women are fever, cough, and dyspnea. Angiotensin-converting enzyme 2 (ACE2) has transient overexpression and increased activity during pregnancy, which is now confirmed as the receptor of SARS-CoV-2 and plays essential roles in human infection and transmission. There is no evidence that pregnant women are more susceptible to SARS-CoV-2. To date, there is no valid medication or vaccination. The immune suppression or modulation during pregnancy increases the risk of severe pneumonia. Remdesivir is an antiviral medication targeting ribonucleic acid (RNA) synthesis that has clinical improvement in the treatment of SARS-CoV-2. Chloroquine is controversial in its effectiveness and safety to treat SARS-CoV-2. Remdesivir is safe in pregnancy. Chloroquine has not been formally assigned to a pregnancy category by the Food and Drug Administration (FDA). The management strategy includes monitoring fetal heart rate and uterine contractions; early oxygenation if O2 saturation is less than 95%; empiric antibiotics for prevention of secondary infection; corticosteroid to treat maternal SARS-CoV-2 disease routinely is not suggested, only for fetal lung maturation in selected cases; and consideration of delivery is according to the obstetric indication, gestational age, and severity of the disease. During epidemics, delivery at 32-34 weeks is considered. The indication for the Cesarean section should be flexible to minimize the risk of infection during the delivery. The newborn should be in isolation ward immediately after birth; breastfeeding is not contraindicated but should avoid direct transmission infection.

Identifiants

pubmed: 32902940
doi: 10.1097/JCMA.0000000000000362
pii: 02118582-202009000-00008
pmc: PMC7434025
doi:

Substances chimiques

Peptidyl-Dipeptidase A EC 3.4.15.1
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

812-816

Références

Am J Obstet Gynecol. 2020 Jun;222(6):521-531
pubmed: 32217113
J Chin Med Assoc. 2020 Aug;83(8):710-711
pubmed: 32349031
Infect Dis Clin North Am. 2019 Dec;33(4):869-889
pubmed: 31668196
J Med Virol. 2020 Oct;92(10):1759-1760
pubmed: 32275075
Nature. 2020 May;581(7806):22-26
pubmed: 32367025
Infect Disord Drug Targets. 2021;21(3):311-313
pubmed: 32389117
Clin Infect Dis. 2020 Nov 19;71(16):2042-2044
pubmed: 32392330
PLoS One. 2020 Apr 16;15(4):e0230295
pubmed: 32298273
Viruses. 2015 May 07;7(5):2358-77
pubmed: 26008694
Lancet Infect Dis. 2018 Oct;18(10):1097-1107
pubmed: 30195996
Lancet Infect Dis. 2018 Oct;18(10):1051-1052
pubmed: 30195997
Am J Obstet Gynecol. 2004 Jul;191(1):292-7
pubmed: 15295381
Nat Med. 2020 Jun;26(6):861-868
pubmed: 32327757
Am J Obstet Gynecol. 2020 Jul;223(1):9-11
pubmed: 32360111
Cell Res. 2020 Mar;30(3):269-271
pubmed: 32020029
Pediatr Dev Pathol. 2020 May-Jun;23(3):177-180
pubmed: 32397896
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100135
pubmed: 32391520
Viruses. 2020 Feb 10;12(2):
pubmed: 32050635
Pathology. 2006 Jun;38(3):210-8
pubmed: 16753741
Endocrinology. 2004 Oct;145(10):4703-11
pubmed: 15231706
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
BJOG. 2020 Jul;127(8):927-929
pubmed: 32219995
Ultrasound Obstet Gynecol. 2020 May;55(5):586-592
pubmed: 32180292
AJR Am J Roentgenol. 2020 Jul;215(1):127-132
pubmed: 32186894
N Engl J Med. 2020 Jun 18;382(25):e100
pubmed: 32302077
Mol Hum Reprod. 2020 Jun 1;26(6):367-373
pubmed: 32365180
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
J Microbiol Immunol Infect. 2019 Jun;52(3):501-503
pubmed: 29907538
Lancet. 2020 Mar 28;395(10229):1063-1077
pubmed: 32145185
Drug Saf. 2017 Dec;40(12):1205-1218
pubmed: 28689333
J Chin Med Assoc. 2020 Mar;83(3):217-220
pubmed: 32134861
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e364-e365
pubmed: 32379909
Taiwan J Obstet Gynecol. 2020 May;59(3):464-465
pubmed: 32416901
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
J Chin Med Assoc. 2020 Jun;83(6):537-543
pubmed: 32349035
Circ Res. 2000 Sep 1;87(5):E1-9
pubmed: 10969042
BJOG. 2020 Aug;127(9):1109-1115
pubmed: 32369656
J Chin Med Assoc. 2020 May;83(5):508-509
pubmed: 32221153
Mayo Clin Proc. 2020 Jun;95(6):1222-1230
pubmed: 32376099
Trends Microbiol. 2016 Jun;24(6):490-502
pubmed: 27012512
Nature. 2020 Jul;583(7818):830-833
pubmed: 32380511
Am J Obstet Gynecol. 2020 Jul;223(1):109.e1-109.e16
pubmed: 32360108
Medicine (Baltimore). 2018 Dec;97(51):e13293
pubmed: 30572432
Cochrane Database Syst Rev. 2018 Nov 14;11:CD011444
pubmed: 30480761
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
Geburtshilfe Frauenheilkd. 2020 Apr;80(4):380-390
pubmed: 32322107
Am J Obstet Gynecol. 2020 May;222(5):415-426
pubmed: 32105680
Obstet Gynecol. 2020 Jun;135(6):1257-1263
pubmed: 32304512
J Chin Med Assoc. 2020 May;83(5):421-422
pubmed: 32168077
Am J Obstet Gynecol MFM. 2020 May;2(2):100107
pubmed: 32292902
Clin Chest Med. 2011 Mar;32(1):121-132
pubmed: 21277454
Pediatr Infect Dis J. 2020 Jun;39(6):469-477
pubmed: 32398569
Int J Environ Res Public Health. 2020 May 09;17(9):
pubmed: 32397515
Am J Physiol Regul Integr Comp Physiol. 2008 Dec;295(6):R1953-61
pubmed: 18945956
Arch Pathol Lab Med. 2020 Jul 1;144(7):799-805
pubmed: 32180426
J Crit Care. 2020 Jun;57:279-283
pubmed: 32173110
Placenta. 2006 Feb-Mar;27(2-3):200-7
pubmed: 16338465
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
BMJ. 2020 Apr 8;369:m1432
pubmed: 32269046
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Hypertension. 2003 Oct;42(4):749-53
pubmed: 12874086
Am J Obstet Gynecol MFM. 2020 Aug;2(3):100133
pubmed: 32391518
J Mol Med (Berl). 2006 Oct;84(10):814-20
pubmed: 16988814
N Engl J Med. 2020 Apr 23;382(17):1653-1659
pubmed: 32227760
Int J Mol Sci. 2020 May 01;21(9):
pubmed: 32370065

Auteurs

Yu-Ju Lai (YJ)

Department of Obstetrics and Gynecology, Tri-service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Chia-Ming Chang (CM)

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

Chi-Kung Lin (CK)

Department of Obstetrics and Gynecology, Tri-service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Yi-Ping Yang (YP)

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

Chian-Shiu Chien (CS)

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.

Peng-Hui Wang (PH)

Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, ROC.
Female Cancer Foundation, Taipei, Taiwan, ROC.

Cheng-Chang Chang (CC)

Department of Obstetrics and Gynecology, Tri-service General Hospital, National Defense Medical Center, Taipei, Taiwan, ROC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH